Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Amphastar Pharmaceuticals, Inc. (AMPH) had Stock-Based Compensation of $27.28M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$183.10M |
|
$24.43M |
|
$97.44M |
|
$85.67M |
|
$147.50M |
|
$35.61M |
|
$-3.69M |
|
$31.91M |
|
$31.91M |
|
$24.43M |
|
$24.43M |
|
$24.43M |
|
$24.43M |
|
$35.61M |
|
$50.81M |
|
46.74M |
|
48.22M |
|
$0.53 |
|
$0.51 |
|
| Balance Sheet Financials | |
$636.02M |
|
$310.57M |
|
$993.28M |
|
$1.63B |
|
$158.16M |
|
$608.75M |
|
$682.34M |
|
$840.49M |
|
$788.80M |
|
$222.84M |
|
$788.80M |
|
45.65M |
|
| Cash Flow Statement Financials | |
$156.12M |
|
$-70.33M |
|
$-67.42M |
|
$151.84M |
|
$170.41M |
|
$18.57M |
|
|
Stock-Based Compensation |
$27.28M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.02 |
|
-- |
|
-- |
|
0.44 |
|
0.77 |
|
46.79% |
|
19.45% |
|
19.45% |
|
-- |
|
17.43% |
|
13.34% |
|
$121.23M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.55 |
|
1.14 |
|
79.00 |
|
3.10% |
|
10.96% |
|
1.50% |
|
1.75% |
|
$17.28 |
|
$2.51 |
|
$3.24 |
|